Status:
ACTIVE_NOT_RECRUITING
Adherence to Lung Cancer Screening by Low-dose Thoracic CT in Haut-Rhin Department, France.
Lead Sponsor:
Groupe Hospitalier de la Region de Mulhouse et Sud Alsace
Conditions:
High-Risk Cancer
Lung Cancer
Eligibility:
All Genders
50-74 years
Phase:
NA
Brief Summary
The main objective of the study is to measure adherence to a lung cancer screening program using low-dose thoracic CT.
Detailed Description
Secondary objectives 1. To evaluate patient compliance over the entire duration of the screening program 2. To assess patient smoking cessation 3. To describe radiation doses received during CT scans...
Eligibility Criteria
Inclusion
- Patients aged 50 to 74 years
- Smoking OR having smoked (withdrawal of \<15 years): ≥15 cigarettes/day for ≥25 years OR ≥10 cigarettes/day for ≥30 years
- Affiliated or beneficiary of a social security scheme
- Written informed consent
Exclusion
- Inability to walk up two flights of stairs without stopping
- BMI \> 35 kg/m²
- Recent chest CT scan \< 1 year
- Personal history of lung cancer \< 5 years or under treatment
- Personal history of cancer being monitored by chest CT scan
- Contraindication to lung cancer treatment or diagnostic investigations
- Current or recent respiratory symptoms immediately suggestive of lung cancer
- Pregnant or breast-feeding woman
- Person under court protection, guardianship or curatorship
- Person deprived of liberty by judicial or administrative decision.
Key Trial Info
Start Date :
November 6 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2026
Estimated Enrollment :
126 Patients enrolled
Trial Details
Trial ID
NCT06020443
Start Date
November 6 2023
End Date
November 1 2026
Last Update
May 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cabinet de médecine générale
Colmar, Haut-Rhin, France, 68000